Zevra Therapeutics to Report 2023 Fourth Quarter and Full Year Financial Results on March 28, 2024
CELEBRATION, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company) a rare disease...
Month: March 2024
Xerox Holdings Corporation Announces Early Tender Results for 3.800% Senior Notes due 2024 and 5.000% Senior Notes due 2025
Contacts Media: Justin Capella, Xerox, +1-203-258-6535, Justin.Capella@xerox.com Investor: David Beckel, Xerox, +1-203-849-2318, David.Beckel@xerox.com Xerox Holdings Corporation (NASDAQ: XRX) (“Xerox Holdings”)...
VERB’s MARKET.live Adds 100 More Retail Brands to its Livestream Social Shopping Platform
LOS ALAMITOS, Calif. and LAS VEGAS, March 18, 2024 (GLOBE NEWSWIRE) -- Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or...
VERB’s MARKET.live Adds 100 More Retail Brands to its Livestream Social Shopping Platform
LOS ALAMITOS, Calif. and LAS VEGAS, March 18, 2024 (GLOBE NEWSWIRE) -- Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or...
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical...
SolarEdge’s First Commercial Storage System for PV Applications Now Available for Order in Italy
Availability in Italy follows first shipment of the South African version of the new commercial storage system in the fourth...
Eightco announces Paul Vassilakos as Executive Chairman and Chief Executive Officer and Certain Balance Sheet Improvements
Easton, PA, March 18, 2024 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company” or “Eightco”) today announced that...
Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy
CAMBRIDGE, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on...
nCino to Acquire DocFox
Joint capabilities will simplify, automate, and drive efficiency across the onboarding and account opening experience for commercial and business bankingExpands...
American Rare Earths’ Scoping Study confirms low-cost, scalable world-class REE project
DENVER, March 18, 2024 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF and AMRRY) (“ARR” or the...
American Rare Earths’ Scoping Study confirms low-cost, scalable world-class REE project
DENVER, March 18, 2024 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF and AMRRY) (“ARR” or the...
AUXLY TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON MARCH 25, 2024
TORONTO, March 18, 2024 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") announced today that...
Arch Biopartners Clinical Team Publishes Data from Phase II Trial for LSALT Peptide Targeting Organ Inflammation in Hospitalized Patients Infected with SARS-CoV-2
TORONTO, March 18, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF),...
FDA Advisory Committee Votes 8 to 3 in Favor of Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy
DENVER, Colo., Mar 18, 2024 (247marketnews.com)- Bristol Myers Squibb (NYSE:BMY) and 2seventy bio, Inc. (NASDAQ:TSVT) published, after Friday’s market close,...
Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain
Silo reports positive stability of SP-26 for time-release and dosage control SARASOTA, FL, March 18, 2024 (GLOBE NEWSWIRE) -- Silo...
Drilling Tools International Corp. Amends and Extends ABL Credit Facility and Enters into New Term Loan
ABL Amendment Provides Additional Financial Flexibility, Extends Maturity to 2029 and Modifies Certain Financial Covenants New Term Loan Adds $25...
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
ALPHARETTA, Ga., March 18, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies...
AstraZeneca caps patient out-of-pocket costs at $35 per month for its US inhaled respiratory portfolio
Expanded savings programs build on company’s longstanding commitment to addressing barriers to access and affordability for patients Contacts Brendan McEvoy...
Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
STATEN ISLAND, N.Y., March 18, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a clinical...
Global Patient Survey Results Reveal Significant Negative Impact on Social, Emotional and Mental Well-Being for People Living with Low-Grade Serous Ovarian Cancer
Findings presented at SGO 2024 show 87% of respondents afraid of making long-term plans due to the possibility of a...
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights
– Dose escalation ongoing in four clinical-stage precision oncology programs; TNG908 phase 1/2 clinical data expected in 2024 – –...
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
Contacts Investors & Media Brian Moore Vice President, Investor Relations and Corporate Development (626) 303-7902, Ext. 3023 bmoore@staar.com STAAR Surgical...
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
– Steven Closter brings more than 30 years of commercial experience in the biopharmaceutical industry to Syndax – – Company...
Simply Good Foods to Report Second Quarter Fiscal Year 2024 Financial Results on Thursday, April 4, 2024
DENVER, March 18, 2024 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”),...
DoD Extends Contract for ORAN-based Private 5G Networks through 2025
Contract Extension Awarded for 5G Deployments at bases in Washington and Hawaii to Help DoD Evaluate 5G Applications and LEO/GEO SATCOM...
Protagonist Therapeutics Announces Closing of Worldwide Rusfertide License and Collaboration Agreement with Takeda
NEWARK, CA / ACCESSWIRE / March 18, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announces the closing...
Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses
ZUG, Switzerland, March 18, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2...
Phoenix & InductEV Form Long-Term Partnership for Wireless Vehicle Charging
ANAHEIM, CA and KING OF PRUSSIA, PA / ACCESSWIRE / March 18, 2024 / Phoenix Motor Inc. (Nasdaq:PEV), a leading...
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
Contacts Media Relations Denise Landry DeniseLandry@orthofix.com 214.937.2529 Investor Relations Louisa Smith, Gilmartin Group IR@orthofix.com Orthofix Medical Inc. (NASDAQ:OFIX), a leading...
Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera™ in Stage II Colorectal Cancer
Contacts Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350, investor@natera.com Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com...
NetEase Experts Spotlight Cutting-Edge Game Technology at GDC 2024
HANGZHOU, China, March 18, 2024 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), one of...
Mercury Announces Early Access Program for New Direct RF Multi-Chip Module Powered by AMD Versal Adaptive SoCs
ANDOVER, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical...
Mobilicom to Showcase its Field-Proven Cybersecure Drone Solutions at the Association of the U.S. Army’s Annual Global Force Symposium & Expo
Mobilicom’s military-grade cybersecurity solutions include ground, aerial, and maritime unmanned drone and robotics platforms that operate in the most stringent...
Mobilicom to Showcase its Field-Proven Cybersecure Drone Solutions at the Association of the U.S. Army’s Annual Global Force Symposium & Expo
Mobilicom’s military-grade cybersecurity solutions include ground, aerial, and maritime unmanned drone and robotics platforms that operate in the most stringent...
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
CAMBRIDGE, Mass., March 18, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology...
Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets
RA'ANANA, Israel, March 18, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira"), a...
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
Poster presentations to highlight new quantitative and serologic diagnostic methods for Celiac Disease detection and determination of intestinal mucosal healthRead...
Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer
―Industry veteran with late-stage clinical development, medical affairs, and regulatory experience; well-positioned to advance losmapimod towards a potential regulatory submission...
JOANN to Reduce Debt and Receive $132 Million in New Capital and Financial Accommodations
DENVER, Colo., Mar 18, 2024 (247marketnews.com)- JOANN Inc. (NASDAQ:JOAN) stated, Sunday night, that it received commitments for approximately $132 million...
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing...